HLA class Ib molecules and immune cells in pregnancy and preeclampsia

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Djurisic, S ^a   Hviid, T Vauvert F ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

HLA class Ib; HLA E; HLA F; HLA G; Immune Cells; Preeclampsia

Indexed keywords

HLA B ANTIGEN; HLA B1 ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; ISOPROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; IMMUNE RESPONSE; IMMUNOMODULATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; TH17 CELL; TROPHOBLAST;

EID: 84919487875     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00652     Document Type: Article

References (206)

1. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Human reproduction. 1991;6(6):791-8.
2. Moffett-King A. Natural killer cells and pregnancy. Nature reviews Immunology. 2002;2(9):656-63.
3. Saito S, Shiozaki A, Sasaki Y, Nakashima A, Shima T, Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol. 2007;29(2):115-22.
4. Doherty PC, Zinkernagel RM. A biological role for the major histocompatibility antigens. Lancet. 1975;1(7922):1406-9.
5. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature. 1999;401(6756):921-3.
6. Redman CW, McMichael AJ, Stirrat GM, Sunderland CA, Ting A. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. Immunology. 1984;52(3):457-68.
7. Geraghty DE, Koller BH, Orr HT A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proceedings of the National Academy of Sciences of the United States of America. 1987;84(24):9145-9.
8. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. Journal of immunology. 1990;144(2):731-5.
9. Schmidt CM, Orr HT. A physical linkage map of HLA-A, -G, -7.5p, and -F. Human immunology. 1991;31(3):180-5.
10. Loke YW, King A, Burrows TD. Decidua in human implantation. Human reproduction. 1995;10Suppl 2:14-21.
11. Blaschitz A, Hutter H, Dohr G. HLA Class I protein expression in the human placenta. Early pregnancy. 2001;5(1):67-9.
12. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. Journal of immunology. 2003;171(3):1376- 84.
13. Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction. 2006;131(3):583-9.
14. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248(4952):220-3.
15. Chumbley G, King A, Holmes N, Loke YW. In situ hybridization and northern blot demonstration of HLA-G mRNA in human trophoblast populations by locus-specific oligonucleotide. Human immunology. 1993;37(1):17-22.
16. Shobu T, Sageshima N, Tokui H, Omura M, Saito K, Nagatsuka Y, et al. The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. Journal of reproductive immunology. 2006;72(1-2):18-32.
17. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(15):8856-61.
18. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proceedings of the National Academy of Sciences of the United States of America. 2006;103(44):16412-7.
19. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS biology. 2006;4(l):e9.
20. koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. Journal of immunology. 1988;141(3):897-904.
21. Pietra G, Romagnani C, Manzini C, Moretta L, Mingari MC. The emerging role of HLA-Erestricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. Journal of biomedicine & biotechnology. 2010;2010:907092.
22. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(9):5199-204.
23. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. European journal of immunology. 1998;28(9):2854- 63.
24. OCallaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, et al. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell. 1998;1(4):531-41.
25. Lee N, Geraghty DE. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. Journal of immunology. 2003;171(10):5264-71.
26. Lee N, Ishitani A, Geraghty DE. HLA-F is a surface marker on activated lymphocytes. European journal of immunology. 2010.
27. Goodridge JP, Burian A, Lee N, Geraghty DE. HLA-F complex without peptide binds to MHC class I protein in the open conformer form. Journal of immunology. 2010;184(11):6199- 208.
28. Arosa FA, Santos SG, Powis SJ. Open conformers: the hidden face of MHC-I molecules. Trends in immunology. 2007;28(3):115-23.
29. Allan DS, Lepin EJ, Braud VM, OCallaghan CA, McMichael AJ. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. Journal of immunological methods. 2002;268(1):43-50.
30. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(9):3947-51.
31. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of immunology. 1994;153(12):5516- 24.
32. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(10):4209-13.
33. Hviid TV, Moller C, Sorensen S, Morling N. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Human immunology. 1998;59(2):87-98.
34. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Human immunology. 2000;61(11):1138-49.
35. Emmer PM, Joosten I, Schut MH, Zusterzeel PL, Hendriks JC, Steegers EA. Shift in expression of HLA-G mRNA spliceforms in pregnancies complicated by preeclampsia. Journal of the Society for Gynecologic Investigation. 2004;11(4):220-6.
36. Geraghty DE, Pei J, Lipsky B, Hansen JA, Taillon-Miller P, Bronson SK, et al. Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes. Proceedings ofthe National Academy of Sciences of the United States of America. 1992;89(7):2669-73.
37. Moscoso J, Serrano-Vela JI, Pacheco R, Arnaiz-Villena A. HLA-G, -E and -F: allelism, function and evolution. Transplant immunology. 2006;17(1):61-4.
38. Alegre E, Diaz-Lagares A, Lemaoult J, Lopez-Moratalla N, Carosella ED, Gonzalez A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Human immunology. 2007;68(8):661-7.
39. Feger U, Tolosa E, Huang YH, Waschbisch A, Biedermann T, Melms A, et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood. 2007;110(2):568-77.
40. Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, et al. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol. 2005;159(1-2):155-64.
41. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. International immunology. 1999;11(5):803-11.
42. Larsen MH, Bzorek M, Pass MB, Larsen LG, Nielsen MW, Svendsen SG, et al. Human leukocyte antigen-G in the male reproductive system and in seminal plasma. Molecular human reproduction. 2011;17(12):727-38.
43. Langat DK, Sue Platt J, Tawfik O, Fazleabas AT, Hunt JS. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. Journal of reproductive immunology. 2006;71(1):75-86.
44. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression ofthe class Ib HLA-G molecule with fet al trophoblasts. The Journal of experimental medicine. 1997;186(2):289-98.
45. Rizzo R, Stignani M, Melchiorri L, Baricordi OR. Possible role of human leukocyte antigen-G molecules in human oocyte/embryo secretome. Human immunology. 2009;70(12):970-5.
46. Yao GD, Shu YM, Shi SL, Peng ZF, Song WY, Jin HX, et al. Expression and potential roles of HLA-G in human spermatogenesis and early embryonic development. PloS one. 2014;9(3):e92889.
47. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood. 2004;104(10):3153-60.
48. Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH. Increased fet al erythroblasts in women who subsequently develop pre-eclampsia. Human reproduction. 2000;15(7):1624- 8.
49. Lepin EJ, Bastin JM, Allan DS, Roncador G, Braud VM, Mason DY, et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. European journal of immunology. 2000;30(12):3552-61.
50. Hunt JS, Geraghty DE. Soluble HLA-G isoforms: technical deficiencies lead to misinterpretations. Molecular human reproduction. 2005;11(10):715-7.
51. Jabeen A, Miranda-Sayago JM, Obara B, Spencer PS, Dealtry GB, Hayrabedyan S, et al. Quantified colocalization reveals heterotypic histocompatibility class I antigen associations on trophoblast cell membranes: relevance for human pregnancy. Biology of reproduction. 2013;89(4):94.
52. Shaikly V, Shakhawat A, Withey A, Morrison I, Taranissi M, Dealtry GB, et al. Cell bioimaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos. Reproductive biomedicine online. 2010;20(2):223-33.
53. Howangyin KY, Loustau M, Wu J, Alegre E, Daouya M, Caumartin J, et al. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cellular and molecular life sciences: CMLS. 2012.
54. Guo Y, Lee CL, So KH, Gao J, Yeung WS, Yao Y, et al. Soluble human leukocyte antigen-g5 activates extracellular signal-regulated protein kinase signaling and stimulates trophoblast invasion. PloS one. 2013;8(10):e76023.
55. Alegre E, Rebmann V, Lemaoult J, Rodriguez C, Horn PA, Diaz-Lagares A, et al. In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes. European journal of immunology. 2013;43(7):1933-9.
56. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and preeclampsia. Placenta. 2008;29 Suppl A:S73-7.
57. Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, Koopman LA, et al. Disulfide bondmediated dimerization of HLA-G on the cell surface. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(25):16180-5.
58. Gonen-Gross T, Achdout H, Gazit R, Hanna J, Mizrahi S, Markel G, et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. Journal of immunology. 2003;171(3):1343-51.
59. Morales PJ, Pace JL, Platt JS, Langat DK, Hunt JS. Synthesis of beta(2)-microglobulinfree, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology. 2007;122(2):179-88.
60. Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. European journal of immunology. 2007;37(7):1924-37.
61. Pfeiffer KA, Rebmann V, Passler M, van der Ven K, van der Ven H, Krebs D, et al. Soluble HLA levels in early pregnancy after in vitro fertilization. Human immunology. 2000;61(6):559-64.
62. Rizzo R, Andersen AS, Lassen MR, Sorensen HC, Bergholt T, Larsen MH, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. American journal of reproductive immunology. 2009;62(5):320-38.
63. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. American journal of obstetrics and gynecology. 2000;183(3):682-8.
64. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. American journal of reproductive immunology. 2007;57(4):277-86.
65. Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Molecular human reproduction. 2000;6(1):88-95.
66. Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G" and anticytokeratin antibody "CAM5.2". American journal of reproductive immunology. 1996;36(6):349-58.
67. Colbern GT, Chiang MH, Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. American journal of obstetrics and gynecology. 1994;170(5Pt1):1244-50.
68. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. American journal of obstetrics and gynecology. 2005;193(1):204-8.
69. Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Reduced thirdtrimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. American journal of obstetrics and gynecology. 2007;197(3):255 e1-5.
70. Darmochwal-Kolarz D, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. Folia Histochem Cytobiol. 2012;50(2):286-91.
71. Hviid TV, Larsen LG, Hoegh AM, Bzorek M. HLA-G expression in placenta in relation to HLA-G genotype and polymorphisms. American journal of reproductive immunology. 2004;52(3):212-7.
72. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue antigens. 2008;72(4):335-41.
73. OBrien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cellular and molecular life sciences: CMLS. 2001;58(12-13):1943-9.
74. Moreau P, Contu L, Alba F, Lai S, Simoes R, Orru S, et al. HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage. Biology of reproduction. 2008;79(3):459-67.
75. Yie SM, Li LH, Xiao R, Librach CL. A single base-pair mutation in the 3-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Molecular human reproduction. 2008;14(11):649-53.
76. Larsen MH, Hylenius S, Andersen AM, Hviid TV. The 3-untranslated region of the HLAG gene in relation to pre-eclampsia: revisited. Tissue antigens. 2010;75(3):253-61.
77. Vianna P, Dalmaz CA, Veit TD, Tedoldi C, Roisenberg I, Chies JA. Immunogenetics of pregnancy: role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic Brazilian women. Human immunology. 2007;68(8):668-74.
78. Iversen AC, Nguyen OT, Tommerdal LF, Eide IP, Landsem VM, Acar N, et al. The HLA-G 14bp gene polymorphism and decidual HLA-G 14bp gene expression in pre-eclamptic and normal pregnancies. Journal of reproductive immunology. 2008;78(2): 158-65.
79. Aldrich C, Verp MS, Walker MA, Ober C. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation. Journal of reproductive immunology. 2000;47(1):41-8.
80. Lin A, Yan WH, Dai MZ, Chen XJ, Li BL, Chen BG, et al. Maternal human leukocyte antigen-G polymorphism is not associated with pre-eclampsia in a Chinese Han population. Tissue antigens. 2006;68(4):311-6.
81. Lynge Nilsson L, Djurisic S, Hviid TV. Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction. Front Immunol. 2014;5:198.
82. McIntire RH, Sifers T, Platt JS, Ganacias KG, Langat DK, Hunt JS. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords. Placenta. 2008;29(7):631-8.
83. Chen BL, Z; Learoyd, J; Singleton, P; Ober, C; Sperling, AI; White, SR; Solway, J. Soluble HLA-G5 Dimer Activates SHP2 And Akt Through The LILRB2 Receptor In Human Airway Smooth Muscle. Am J Respir Crit Care Med. 2012;185:A4290.
84. Fons P, Chabot S, Cartwright JE, Lenfant F, LFaqihi F, Giustiniani J, et al. Soluble HLAG1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood. 2006;108(8):2608-15.
85. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. Journal of immunology. 2003;171(11):6215-24.
86. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. European journal of immunology. 2002;32(12):3576-86.
87. Zhang WQ, Xu DP, Liu D, Li YY, Ruan YY, Lin A, et al. HLA-G1 and HLA-G5 isoforms have an additive effect on NK cytolysis. Human immunology. 2014;75(2):182-9.
88. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics. 2003;55(2):63-79.
89. Blaschitz A, Juch H, Volz A, Hutter H, Daxboeck C, Desoye G, et al. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4- containing HLA-G5 and HLA-G6 isoforms. Molecular human reproduction. 2005;11(10):699- 710.
90. Ober C, Aldrich CL. HLA-G polymorphisms: neutral evolution or novel function? Journal of reproductive immunology. 1997;36(1-2):1-21.
91. Park GM, Lee S, Park B, Kim E, Shin J, Cho K, et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochemical and biophysical research communications. 2004;313(3):606-11.
92. Rizzo R, Baricordi OR. Focus on the importance of soluble human leukocyte antigen G as a marker for embryo selection in assisted reproductive technology. Fertility and sterility. 2013;100(6):e43.
93. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and - G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecific CTL cytolysis. Journal of immunology. 2001;166(8):5018-26.
94. Teklemariam T, Zhao L, Hantash BM. Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization. Human immunology. 2012;73(9):898-905.
95. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Human molecular genetics. 1993;2(12):2200.
96. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3 UT region of the HLA-G gene influences HLA-G mRNA stability. Human immunology. 2003;64(11):1005-10.
97. Hiby SE, King A, Sharkey A, Loke YW. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue antigens. 1999;53(1):1-13.
98. Svendsen SG, Hantash BM, Zhao L, Faber C, Bzorek M, Nissen MH, et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3-untranslated region. Human immunology. 2013;74(7):818-27.
99. Robillard PY. Interest in preeclampsia for researchers in reproduction. Journal of reproductive immunology. 2002;53(1-2):279-87.
100. Arnaiz-Villena A, Morales P, Gomez-Casado E, Castro MJ, Varela P, Rojo-Amigo R, et al. Evolution of MHC-G in primates: a different kind of molecule for each group of species. Journal of reproductive immunology. 1999;43(2):111-25.
101. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Human reproduction update. 2006;12(3):209-32.
102. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol. 2011;28(11):3069-86.
103. Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Molecular human reproduction. 2004;10(4):237-46.
104. Tan CY, Ho JF, Chong YS, Loganath A, Chan YH, Ravichandran J, et al. Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies. Molecular human reproduction. 2008;14(5):317-24.
105. Bermingham J, Jenkins D, McCarthy T, OBrien M. Genetic analysis of insulin-like growth factor II and HLA-G in pre-eclampsia. Biochemical Society transactions. 2000;28(2):215-9.
106. Zhang Z, Li Y, Zhang LL, Jia LT, Yang XQ. Association of 14 bp insertion/deletion polymorphism of the HLA-G gene in father with severe preeclampsia in Chinese. Tissue antigens. 2012;80(2):158-64.
107. Shabalina SA, Spiridonov NA, Kashina A. Sounds of silence: synonymous nucleotides as a key to biological regulation and complexity. Nucleic acids research. 2013;41(4):2073-94.
108. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates inJEG-3 cells. Human reproduction. 2006;21(7):1743-8.
109. Castelli EC, Moreau P, Oya e Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L, et al. In silico analysis of microRNAS targeting the HLA-G 3untranslated region alleles and haplotypes. Human immunology. 2009;70(12):1020-5.
110. Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, et al. Polymorphic sites at the 3 untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PloS one. 2013;8(10):e71742.
111. Loisel DA, Billstrand C, Murray K, Patterson K, Chaiworapongsa T, Romero R, et al. The maternal HLA-G 1597DeltaC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women. Molecular human reproduction. 2013;19(3):144-52.
112. Matte C, Lacaille J, Zijenah L, Ward B, Roger M. HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Human immunology. 2000;61(11):1150-6.
113. Tian W, Cai JH, Wang F, Li LX, Cao Y. HLA-G*0105N and HLA-G 14 bp dimorphisms in exon 8 in four distinct populations in mainland China. Tissue antigens. 2010;75(3):227-34.
114. Grimsley C, Kawasaki A, Gassner C, Sageshima N, Nose Y, Hatake K, et al. Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data. Tissue antigens. 2002;60(3):206-12.
115. Ulbrecht M, Couturier A, Martinozzi S, Pla M, Srivastava R, Peterson PA, et al. Cell surface expression of HLA-E: interaction with human beta2-microglobulin and allelic differences. European journal of immunology. 1999;29(2):537-47.
116. Grimsley C, Ober C. Population genetic studies of HLA-E: evidence for selection. Human immunology. 1997;52(1):33-40.
117. Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. The Journal of biological chemistry. 2003;278(7):5082-90.
118. Hirankarn N, Kimkong I, Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue antigens. 2004;64(5):588-92.
119. Tripathi P, Naik S, Agrawal S. HLA-E and immunobiology of pregnancy. Tissue antigens. 2006;67(3):207-13.
120. Bueno-Sanchez JC, Pena-Alzate S, Pena RB, Agudelo-Jaramillo B, Cadavid-Jaramillo AP, Chaouat G, et al. Sera from early-onset, severely preeclamptic women directly modulate HLAE expression in the EA.hy296 endothelial cell line. Journal of reproductive immunology. 2014.
121. de Groot CJ, van der Mast BJ, Visser W, De Kuiper P, Weimar W, Van Besouw NM. Preeclampsia is associated with increased cytotoxic T-cell capacity to paternal antigens. American journal of obstetrics and gynecology. 2010;203(5):496 e1-6.
122. Hiby SE, Walker JJ, OShaughnessy K M, Redman CW, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fet al HLA-C genes influence the risk of preeclampsia and reproductive success. The Journal of experimental medicine. 2004;200(8):957-65.
123. Dekker G, Robillard PY. Pre-eclampsia: Is the immune maladaptation hypothesis still standing? An epidemiological update. Journal of reproductive immunology. 2007;76(1-2):8- 16.
124. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. Journal of leukocyte biology. 2013;94(2):247-57.
125. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-4.
126. Amodio G, Sales de Albuquerque R, Gregori S. New insights into HLA-G mediated tolerance. Tissue antigens. 2014;84(3):255-63.
127. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2005;19(7):681-93.
128. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. The Journal of experimental medicine. 2003;198(8):1201-12.
129. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fet al-maternal interface. Nature medicine. 2006;12(9):1065-74.
130. Bachmayer N, Sohlberg E, Sundstrom Y, Hamad RR, Berg L, Bremme K, et al. Women with pre-eclampsia have an altered NKG2A and NKG2C receptor expression on peripheral blood natural killer cells. American journal of reproductive immunology. 2009;62(3):147-57.
131. Bachmayer N, Rafik Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E. Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NKcell promoting cytokine interleukin-12 in pre-eclampsia. American journal of reproductive immunology. 2006;56(5-6):292-301.
132. Rajagopalan S, Long EO. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol. 2012;3:258.
133. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. The Journal of experimental medicine. 1997;186(11):1809-18.
134. Goodridge JP, Witt CS, Christiansen FT, Warren HS. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. Journal of immunology. 2003;171(4):1768-74.
135. Tan CY, Chong YS, Loganath A, Chan YH, Ravichandran J, Lee CG, et al. Possible genegene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia. Reproductive sciences. 2009;16(12):1135-43.
136. Fu B, Li X, Sun R, Tong X, Ling B, Tian Z, et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fet al interface. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(3):E231-40.
137. Molvarec A, Ito M, Shima T, Yoneda S, Toldi G, Stenczer B, et al. Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia. American journal of obstetrics and gynecology. 2010;203(6):567 e1-8.
138. Toldi G, Svec P, Vasarhelyi B, Meszaros G, Rigo J, Tulassay T, et al. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta obstetricia et gynecologica Scandinavica. 2008;87(11):1229-33.
139. Munz C, Holmes N, King A, Loke YW, Colonna M, Schild H, et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. The Journal of experimental medicine. 1997;185(3):385-91.
140. Chen BG, Xu DP, Lin A, Yan WH. NK cytolysis is dependent on the proportion of HLA-G expression. Human immunology. 2013;74(3):286-9.
141. Apps R, Sharkey A, Gardner L, Male V, Kennedy P, Masters L, et al. Ex vivo functional responses to HLA-G differ between blood and decidual NK cells. Molecular human reproduction. 2011;17(9):577-86.
142. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fet al relationship: is successful pregnancy a TH2 phenomenon? Immunology today. 1993;14(7):353-6.
143. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. Journal of reproductive immunology. 2003;59(2):161-73.
144. Rieger L, Hofmeister V, Probe C, Dietl J, Weiss EH, Steck T, et al. Th1- and Th2-like cytokine production by first trimester decidual large granular lymphocytes is influenced by HLA-G and HLA-E. Molecular human reproduction. 2002;8(3):255-61.
145. van der Meer A, Lukassen HG, van Lierop MJ, Wijnands F, Mosselman S, Braat DD, et al. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Molecular human reproduction. 2004;10(3):189-95.
146. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, et al. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Molecular human reproduction. 2001;7(2):195-200.
147. Chaouat G. Innately moving away from the Th1/Th2 paradigm in pregnancy. Clinical and experimental immunology. 2003;131(3):393-5.
148. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63(6):601-10.
149. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clinical and experimental immunology. 2010;159(2):109-19.
150. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. Journal of immunology. 2009;183(11):7023-30.
151. Wu HX, Jin LP, Xu B, Liang SS, Li DJ. Decidual stromal cells recruit Th17 cells into decidua to promote proliferation and invasion of human trophoblast cells by secreting IL-17. Cellular & molecular immunology. 2014;11(3):253-62.
152. Toldi G, Rigo J, Jr., Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17- producing peripheral blood lymphocytes in pre-eclampsia. American journal of reproductive immunology. 2011;66(3):223-9.
153. Guerin LR, Prins JR, Robertson SA Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Human reproduction update. 2009;15(5):517-35.
154. Zhao JX, Zeng YY, Liu Y. Fet al alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. Journal of reproductive immunology. 2007;75(2):71-81.
155. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004;112(1):38-43.
156. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nature immunology. 2004;5(3):266-71.
157. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fet al rejection in a murine abortion model. The American journal of pathology. 2005;166(3):811-22.
158. MjosbergJ, BergG, Ernerudh J, Ekerfelt C. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology. 2007;120(4):456-66.
159. Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertension in pregnancy. 2009;28(3):300-11.
160. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clinical and experimental immunology. 2007;149(1):139-45.
161. Paeschke S, Chen F, Horn N, Fotopoulou C, Zambon-Bertoja A, Sollwedel A, et al. Preeclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. American journal of reproductive immunology. 2005;54(6):384-9.
162. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. Journal of reproductive immunology. 2012;93(2):75-81.
163. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. Translational mini-review series on Th17 cells: induction ofinterleukin-17 production by regulatory T cells. Clinical and experimental immunology. 2010;159(2):120-30.
164. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunology and cell biology. 2010;88(6):615-7.
165. Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible. Journal of leukocyte biology. 2009;86(2):273-81.
166. Li C, Toth I, Schulze Zur Wiesch J, Pereyra F, Rychert J, Rosenberg ES, et al. Functional characterization of HLA-G(+) regulatory T cells in HIV-1 infection. PLoS pathogens. 2013;9(1):e1003140.
167. Amodio G, Mugione A, Sanchez AM, Vigano P, Candiani M, Somigliana E, et al. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Human immunology. 2013;74(4):406-11.
168. Hsu P, Santner-Nanan B, Joung S, Peek MJ, Nanan R. Expansion of CD4(+) HLA-G(+) T Cell in human pregnancy is impaired in pre-eclampsia. American journal of reproductive immunology. 2014;71(3):217-28.
169. Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, Daouya M, et al. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood. 2007;110(12):3936-48.
170. Mincheva-Nilsson L, Baranov V, Yeung MM, Hammarstrom S, Hammarstrom ML. Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy. Journal of immunology. 1994;152(4):2020-32.
171. Naji A, MenierC, Morandi F, Agaugue S, Maki G, Ferretti E, et al. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses. Journal of immunology. 2014;192(4):1536-46.
172. Jensen F, Wallukat G, Herse F, Budner O, El-Mousleh T, Costa SD, et al. CD19+CD5+ cells as indicators of preeclampsia. Hypertension. 2012;59(4):861-8.
173. Zeng B, Kwak-Kim J, Liu Y, Liao AH. Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation. American journal of reproductive immunology. 2013;70(6):454-63.
174. Gardner L, Moffett A. Dendritic cells in the human decidua. Biology of reproduction. 2003;69(4):1438-46.
175. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, et al. Differentiation of type 1T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10- dependent ILT4/HLA-G pathway. Blood. 2010;116(6):935-44.
176. LeFriecG, Gros F, Sebti Y, Guilloux V, Pangault C, Fauchet R, et al. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. Journal of leukocyte biology. 2004;76(6):1125-33.
177. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, et al. Coexpression ofCD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nature medicine. 2013;19(6):739-46.
178. Bacchetta R, Gregori S, Serafini G, Sartirana C, Schulz U, Zino E, et al. Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica.2010;95(12):2134-43.
179. Liang S, Horuzsko A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Human immunology. 2003;64(11):1025-32.
180. Panda B, Panda A, Ueda I, Abrahams VM, Norwitz ER, Stanic AK, et al. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. Journal of reproductive immunology. 2012;94(2):210-5.
181. Huang SJ, Chen CP, Schatz F, Rahman M, Abrahams VM, Lockwood CJ. Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua. The Journal of pathology. 2008;214(3):328-36.
182. Rieger L, Honig A, Sutterlin M, Kapp M, Dietl J, Ruck P, et al. Antigen-presenting cells in human endometrium during the menstrual cycle compared to early pregnancy. Journal of the Society for Gynecologic Investigation. 2004;11(7):488-93.
183. KimJS, Romero R, Cushenberry E, KimYM, Erez O, Nien JK, et al. Distribution of CD14+ and CD68+ macrophages in the placental bed and basal plate of women with preeclampsia and preterm labor. Placenta. 2007;28(5-6):571-6.
184. Mizuno M, Aoki K, Kimbara T. Functions of macrophages in human decidual tissue in early pregnancy. American journal of reproductive immunology. 1994;31(4):180-8.
185. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. Journal of leukocyte biology. 2004;76(3):509-13.
186. Reister F, Frank HG, Heyl W, Kosanke G, Huppertz B, Schroder W, et al. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta. 1999;20(2-3):229-33.
187. Nagamatsu T, Schust DJ. The immunomodulatory roles of macrophages at the maternal-fet al interface. Reproductive sciences. 2010;17(3):209-18.
188. Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstetrics and gynecology. 1992;79(1):19-26.
189. Katabuchi H, Yih S, Ohba T, Matsui K, Takahashi K, Takeya M, et al. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Medical electron microscopy: official journal of the Clinical Electron Microscopy Society of Japan. 2003;36(4):253-62.
190. Li M, Wu ZM, Yang H, Huang SJ. NFkappaB and JNK/MAPK activation mediates the production of major macrophage- or dendritic cell-recruiting chemokine in human first trimester decidual cells in response to proinflammatory stimuli. The Journal of clinical endocrinology and metabolism. 2011;96(8):2502-11.
191. Huang SJ, Zenclussen AC, Chen CP, Basar M, Yang H, Arcuri F, et al. The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia. The American journal of pathology. 2010;177(5):2472-82.
192. Pathak N, Sawhney H, Vasishta K, Majumdar S. Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia. The Australian & New Zealand journal of obstetrics & gynaecology. 1999;39(4):484-7.
193. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. The Journal of clinical endocrinology and metabolism. 2004;89(2):812-22.
194. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. The American journal of pathology. 2002;160(4):1405-23.
195. Li C, Houser BL, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(14):5767-72.
196. Classen A, Lloberas J, Celada A. Macrophage activation: classical versus alternative. Methods in molecular biology. 2009;531:29-43.
197. Schonkeren D, van der Hoorn ML, Khedoe P, Swings G, van Beelen E, Claas F, et al. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. The American journal of pathology. 2011;178(2):709-17.
198. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA: the journal of the American Medical Association. 1991;266(2):237-41.
199. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993;341(8858):1447-51.
200. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. The New England journal of medicine. 2002;346(1):33-8.
201. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fet al antigen. Nature. 2012;490(7418):102-6.
202. Kahn DA, Baltimore D. Pregnancy induces a fet al antigen-specific maternal T regulatory cell response that contributes to tolerance. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(20):9299-304.
203. Robertson SA, Guerin LR, Moldenhauer LM, Hayball JD. Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. Journal of reproductive immunology. 2009;83(1-2):109-16.
204. Dahl M, Perin TL, Djurisic S, Rasmussen M, Ohlsson J, Buus S, et al. Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: possible implications for fertility success. American journal of reproductive immunology. 2014;72(1):89-105.
205. Blaschitz A, Juch H, Volz A, Hutter H, Dohr G. Soluble HLA-G, the discussion is going on! Molecular human reproduction. 2005;11(10):723-7.
206. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Disease models & mechanisms. 2012;5(1):9-18.